TREX-1 Inhibitors

TREX-1 inhibitors comprise a diverse array of chemicals that either directly or indirectly modulate the activity of the DNA exonuclease TREX-1. AG-490 indirectly influences TREX-1 through JAK/STAT pathway modulation, while BAY 11-7082 indirectly targets TREX-1 through NF-κB pathway inhibition. 5-Fluorouracil (5-FU) directly inhibits TREX-1 by disrupting DNA synthesis, particularly thymidylate synthase. VX-11e directly inhibits TREX-1 by targeting the DNA repair pathway, specifically inhibiting DNA-PK. ATRA indirectly influences TREX-1 through RAR/RXR pathway modulation, impacting downstream signaling cascades. Cytarabine directly inhibits TREX-1 by incorporating into DNA and disrupting the DNA repair process.

LY294002 indirectly influences TREX-1 through PI3K pathway modulation, while Cisplatin directly inhibits TREX-1 by inducing DNA damage. BMS-345541 indirectly targets TREX-1 through the NF-κB pathway, and SB203580 indirectly influences TREX-1 by modulating the p38 MAPK pathway. Trichostatin A indirectly influences TREX-1 through HDAC inhibition, impacting gene expression. Bafilomycin A1 indirectly influences TREX-1 by targeting the autophagy-lysosome pathway, modulating the degradation of cellular components. These inhibitors provide valuable tools for studying the intricate mechanisms of TREX-1 regulation, shedding light on its role in DNA integrity and implications in various cellular processes.